| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B04B11-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B04B11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-00 |
| filingDate |
1999-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb14b6af9e03059d19a4c420e8ac7d05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c90bce1e10fef6d45cd9c2403b6d49b |
| publicationDate |
2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
YU-23401-A |
| titleOfInvention |
ANTIPARASITIC FORMULATIONS |
| abstract |
A long-acting antiparasitic formulation suitable for topical administration comprising (a) 0.1-50% w / w avermectin or milbemycin having activity against endo- and / or ectoparasites; (b) 1-50% w / z di (C2-4 glycol) mono (C1-4 alkyl) ether; (c) an optional antioxidant; and (d) an optional skin-acceptable volatile solvent g.s. z / z. [A long-acting antiparasitic formulation suitable for topical application including: (a) 0.1-50% w / v an avermectin or milbemycin having activity against endo- and / or ectoparasites; (b) 1-50% v / v a di (C2-4 glycol) mono (C1-4 alkyl) ether; (c) an optional antioxidant; and (d) an optional skin acceptable volatile solvent q.s. v / v. |
| priorityDate |
1998-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |